Duality Biotherapeutics, Inc. (HKG:9606)
169.80
+1.20 (0.71%)
Oct 21, 2026, 3:59 PM HKT
Duality Biotherapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -1,439 | -2,595 | -1,050 | -357.51 | -387.09 |
Depreciation & Amortization | 13.85 | 12.32 | 7.87 | 4.76 | 1.74 |
Other Amortization | - | - | - | 0.23 | 0.06 |
Asset Writedown & Restructuring Costs | - | - | 21.35 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | 1.16 | - |
Stock-Based Compensation | 108.81 | 156.05 | 190.41 | 23.96 | 7.03 |
Other Operating Activities | 31.33 | 2,311 | 855.93 | 903.91 | 20.65 |
Change in Accounts Receivable | 46.55 | 69.39 | -276.77 | -120.97 | -0.75 |
Change in Accounts Payable | 243.75 | 86.52 | 463.06 | 154.46 | 71.04 |
Change in Unearned Revenue | 54.83 | -12.22 | 112.21 | 216.3 | - |
Change in Other Net Operating Assets | 120.5 | 166.5 | -37.86 | -9.95 | -12.16 |
Operating Cash Flow | -818.88 | 194.58 | 285.78 | 816.34 | -299.47 |
Operating Cash Flow Growth | - | -31.91% | -64.99% | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -14.34 | -11.5 | -4.08 | -11.28 | -2.48 |
Sale (Purchase) of Intangibles | -2.36 | -2.22 | -27.1 | -24.62 | -19.72 |
Investment in Securities | -53.58 | -1,894 | -177.46 | - | - |
Other Investing Activities | -22.17 | -4.55 | -2.51 | -42.65 | - |
Investing Cash Flow | -92.45 | -1,913 | -211.15 | -78.55 | -22.2 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Short-Term Debt Issued | - | 141.06 | - | - | - |
Long-Term Debt Issued | - | - | - | - | 135.19 |
Total Debt Issued | 309.08 | 141.06 | - | - | 135.19 |
Long-Term Debt Repaid | - | -4.43 | -3.4 | -138.69 | -1.43 |
Lease Payments | -4.55 | -4.43 | -3.4 | -3.5 | -1.43 |
Net Debt Issued (Repaid) | 304.53 | 136.62 | -3.4 | -138.69 | 133.76 |
Issuance of Common Stock | 14.01 | 1,757 | - | - | - |
Other Financing Activities | -4.69 | -84.65 | -4.22 | -1.59 | -0.89 |
Financing Cash Flow | 245.72 | 1,809 | -7.62 | 10.82 | 451.46 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | -63.08 | -23.33 | 11.01 | 6.31 | 18.42 |
Net Cash Flow | -728.69 | 67.49 | 78.02 | 754.92 | 148.21 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -833.23 | 183.08 | 281.7 | 805.05 | -301.95 |
Free Cash Flow Growth | - | -35.01% | -65.01% | - | - |
Free Cash Flow Margin | -98.94% | 9.89% | 14.51% | 45.06% | -18872.00% |
Free Cash Flow Per Share | -9.32 | 2.81 | 35.21 | 100.63 | -37.74 |
Levered Free Cash Flow | -170.52 | -3,037 | 1,045 | 1,611 | - |
Unlevered Free Cash Flow | -168.53 | -3,037 | 1,045 | 1,611 | - |
Free Cash Flow After Leases | -837.77 | 178.65 | 278.31 | 801.55 | -303.39 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 2.98 | 1.21 | 0.25 | 0.19 | 0.08 |
Cash Income Tax Paid | - | -90.05 | 54.54 | 248.93 | - |
Change in Working Capital | 465.63 | 310.19 | 260.65 | 239.83 | 58.14 |